06/06/2019 05:10:30
Home | Trust In Big Pharma
Editorial
NSF
Contents
Daiichi Jitsugyo
News
Freudenberg
The Pharma Industry Briefing
Fisher Clinical Services Company Insight
Fisher Clinical Services
The People vs Big Pharma: tackling the industry’s trust issues
Scandinavian Health Ltd. Company Insight
Scandinavian Health Ltd.
Humira: the highs and lows of the world’s most successful drug
Wilhelm Haselmeier GmbH & Co KG Company Insight
Wilhelm Haselmeier GmbH & Co. KG
Gene therapy: talking smart solutions with Bluebird Bio
Moehs Iberica Company Insight
Moehs Iberica SL
A research headache: improving the understanding of chronic migraine
Sensitech
HOF Sonderanlagenbau Company Insight
HOF Sonderanlagenbau
Philanthropy in pharma: a look inside the ISPE Foundation
DelSiTech
Novel Oral Therapies Are An Unmet Need For Ulcerative Colitis
Phoenix
FDA removes key barrier to US biosimilar development
Nipro PharmaPackaging
Pfizer price hikes: do rare cancer drugs warrant higher prices?
Alpex
Head-to-head: competing for the most effective psoriasis drug
Mecmesin Company Insight
Mecmesin
Takeda to seek label expansion for Ninlaro in multiple myeloma
Capsugel Company Insight
Contract Pharmaceuticals Limited Canada
Epilepsy: Zogenix’s ZX008 set for showdown with GW Pharma’s Epidiolex
Ecocool
Abiogen Pharma
Illegal online pharmacies: how endemic are they?
Global Freight Solutions Ltd
The boom in medical cannabis research is set to continue
AtoZ-CRO GmbH Company Insight
AtoZ-CRO GmbH
Population boom will boost acute stroke market, particularly in China
Pall Biotech
Cryo Store
Watch Alibaba instead of Amazon in healthcare
WIKA - Disaster prevention
AstraZeneca’s Lynparza maintains lead in PARP inhibitor race
G.F.
Erdmann Design Switzerland
CMV presents a serious concern in HIV+ persons
BEA Technologies
Baxter
bDMARD therapy: adherence in the first year is key to success
Pharma Support Services Ltd Company Insight
Pharma Support Services Ltd
End the struggle: pathways to HEAL the opioid crisis
Lauda
AbbVie poised to overtake Gilead as hepatitis C leader
ILC Dover Inc
ViiV results show the importance of INIs to future HIV treatment
Pfanstiehl
Novartis acquires rights to atopic dermatitis candidate MOR106
Niconex Medical Ltd
Events
Next issue